Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma

Guillermo De Velasco; Wanling Xie; Frede Donskov; Laurence Albiges; Benoit Beuselinck; Sandy Srinivas; Neeraj Agarwal; Jae Lyun Lee; James Brugarolas; Lori A. Wood; Sun young Rha; Christian Kollmannsberger; Scott North; Ravindran Kanesvaran; Brian I. Rini; Reuben Broom; Haru Yamamoto; Marina D. Kaymakcalan; Daniel Y.C. Heng; Toni K. Choueiri

doi:10.1016/j.clgc.2017.01.005

Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma

Guillermo De Velasco, Wanling Xie, Frede Donskov, Laurence Albiges, Benoit Beuselinck, Sandy Srinivas, Neeraj Agarwal, Jae Lyun Lee, James Brugarolas, Lori A. Wood, Sun young Rha, Christian Kollmannsberger, Scott North, Ravindran Kanesvaran, Brian I. Rini, Reuben Broom, Haru Yamamoto, Marina D. Kaymakcalan, Daniel Y.C. Heng, Toni K. Choueiri

Inernational Relations Division

科研成果: 期刊稿件 › 文章 › 同行评审

13 引用（Scopus）

源语言	英语
页（从-至）	403-410.e2
期刊	Clinical Genitourinary Cancer
卷	15
期	3
DOI	https://doi.org/10.1016/j.clgc.2017.01.005
出版状态	已出版 - 6月 2017

!!!ASJC Scopus Subject Areas

肿瘤学
泌尿学

访问文件

10.1016/j.clgc.2017.01.005

其它文件与链接

引用此

De Velasco, G., Xie, W., Donskov, F., Albiges, L., Beuselinck, B., Srinivas, S., Agarwal, N., Lee, J. L., Brugarolas, J., Wood, L. A., Rha, S. Y., Kollmannsberger, C., North, S., Kanesvaran, R., Rini, B. I., Broom, R., Yamamoto, H., Kaymakcalan, M. D., Heng, D. Y. C., & Choueiri, T. K. (2017). Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma. Clinical Genitourinary Cancer, 15(3), 403-410.e2. https://doi.org/10.1016/j.clgc.2017.01.005

De Velasco, G, Xie, W, Donskov, F, Albiges, L, Beuselinck, B, Srinivas, S, Agarwal, N, Lee, JL, Brugarolas, J, Wood, LA, Rha, SY, Kollmannsberger, C, North, S, Kanesvaran, R, Rini, BI, Broom, R, Yamamoto, H, Kaymakcalan, MD, Heng, DYC & Choueiri, TK 2017, 'Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma', Clinical Genitourinary Cancer, 卷 15, 号码 3, 页码 403-410.e2. https://doi.org/10.1016/j.clgc.2017.01.005

@article{b2844f94e54540b4a5084f248c378339,

title = "Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma",

author = "{De Velasco}, Guillermo and Wanling Xie and Frede Donskov and Laurence Albiges and Benoit Beuselinck and Sandy Srinivas and Neeraj Agarwal and Lee, {Jae Lyun} and James Brugarolas and Wood, {Lori A.} and Rha, {Sun young} and Christian Kollmannsberger and Scott North and Ravindran Kanesvaran and Rini, {Brian I.} and Reuben Broom and Haru Yamamoto and Kaymakcalan, {Marina D.} and Heng, {Daniel Y.C.} and Choueiri, {Toni K.}",

note = "Publisher Copyright: {\textcopyright} 2017 Elsevier Inc.",

year = "2017",

month = jun,

doi = "10.1016/j.clgc.2017.01.005",

language = "English",

volume = "15",

pages = "403--410.e2",

journal = "Clinical Genitourinary Cancer",

issn = "1558-7673",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma

AU - De Velasco, Guillermo

AU - Xie, Wanling

AU - Donskov, Frede

AU - Albiges, Laurence

AU - Beuselinck, Benoit

AU - Srinivas, Sandy

AU - Agarwal, Neeraj

AU - Lee, Jae Lyun

AU - Brugarolas, James

AU - Wood, Lori A.

AU - Rha, Sun young

AU - Kollmannsberger, Christian

AU - North, Scott

AU - Kanesvaran, Ravindran

AU - Rini, Brian I.

AU - Broom, Reuben

AU - Yamamoto, Haru

AU - Kaymakcalan, Marina D.

AU - Heng, Daniel Y.C.

AU - Choueiri, Toni K.

PY - 2017/6

Y1 - 2017/6

UR - http://www.scopus.com/inward/record.url?scp=85013080286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013080286&partnerID=8YFLogxK

U2 - 10.1016/j.clgc.2017.01.005

DO - 10.1016/j.clgc.2017.01.005

M3 - Article

C2 - 28254206

AN - SCOPUS:85013080286

SN - 1558-7673

VL - 15

SP - 403-410.e2

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

IS - 3

ER -

Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma

!!!ASJC Scopus Subject Areas

访问文件

其它文件与链接

指纹

引用此